A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent IDH-mutant Astrocytoma or Oligodendroglioma
Clinical trial NCT07120984 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07120984
- Sponsor
- Philogen S.p.A.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2029-01-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.